The effect of temporary hepatic ischemia on liver surface pH and potassium ion activity in the rat
β Scribed by M. Knoop; G. Haller; J. M. Langrehr; C. Dobis; H. Keck; P. Neuhaus
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 514 KB
- Volume
- 380
- Category
- Article
- ISSN
- 1435-2451
No coin nor oath required. For personal study only.
β¦ Synopsis
The effects of hepatic ischemia can be analyzed with a wide variety of functional and morphological methods. In this study we used a new organ monitoring device that accurately determines pH and K + activities on the liver surface with ion-selective electrodes. Four groups of rats (n = 6 each) were subjected to complete, arterial or portal warm ischemia for 15 min (achieved by clamping of the hepatoduodenal ligament, the hepatic artery or the portal vein) and subsequent reperfusion. One group was shamoperated. Complete and portal ischemia were characterized by an immediate decline of pH and a more retarded rise of K + activity on the liver surface. Arterial ischemia had almost no effect on these two parameters when compared with the sham group. Upon reperfusion the shifts of pH and K + activity reversed towards initial baseline values. The organ monitoring system offers the option to assess ional shifts non-invasively during organ procurement, ischemia and reperfusion and may be used as an additional criterion for the estimation of organ viability.
π SIMILAR VOLUMES
We studied the effects of a series of vasodilators on intrahepatic vascular resistance of isolated perfused cirrhotic rat livers in basal conditions and during norepinephrine-induced vasoconstriction. Cirrhosis was induced by repeated intraperitoneal injections of carbon tetrachloride. The vasodilat
adenosine during 20 minutes before ischemia. Prec. / ADA: preconditioned group treated with ADA 20 minutes before preconditioning and for all precondi-
The liver has been judged relatively resistant to ischemia, but prolonged inflow occlusion at normothermic conditions can produce evidence of reversible or irreversible hepatocellular damage. Cytoprotective agents have been used both experimentally and clinically to afford extended viability of hepa